HRV Pharma Acquires German Firm Phatebo to Enter Finished Formulations Market
Hyderabad-based HRV Pharma has acquired 100% equity in German pharmaceutical company Phatebo GmbH from ZeroStack Corp, marking its entry into the European finished formulations market. Founded in 2015 and based in Hilzingen, Phatebo specializes in clinical trial supply and holds a German pharmaceutical wholesale authorization. The acquisition expands HRV Pharma's portfolio beyond active pharmaceutical ingredients, with Phatebo continuing operations under its existing management and name in Germany.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (55/100). Lens Score 38/100.
Outlets measured: businessstandard, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 3 Nov, 12:48 pm. Other outlets followed.
- 1